89 related articles for article (PubMed ID: 3807)
1. [Drug permeation through synthetic lipoid membranes. 7. A resorption model with a lecithin membrane for testing the biological availability of drugs].
Falk M; Fürst W; Lauterbach H
Pharmazie; 1975 Dec; 30(12):775-9. PubMed ID: 3807
[No Abstract] [Full Text] [Related]
2. [Drug permeation through synthetic lipoid membranes. 4. Properties and structure of lecithin-collodium-membranes].
Falk M; Fürst W
Pharmazie; 1974; 29(10-11):715-20. PubMed ID: 4438413
[No Abstract] [Full Text] [Related]
3. [Drug permeation through synthetic lipid membranes. Permeability of lecithin-collodium membranes for drugs and metabolites].
Falk M; Fürst W
Pharmazie; 1974 Sep; 29(9):590-3. PubMed ID: 4420510
[No Abstract] [Full Text] [Related]
4. [Drug permeability through artificial lipoid membranes. 1. Preparation of lecithin membranes].
Fürst W; Falk M
Pharmazie; 1970 Sep; 25(9):546-50. PubMed ID: 5486683
[No Abstract] [Full Text] [Related]
5. [Drug permeation through synthetic lipoid membranes. 9. Studies on the appearance of diffusion layers in relation to membrane composition and permeating drugs].
Lerche D; Becker R; Falk M; Fürst W
Pharmazie; 1976 Nov; 31(11):800-4. PubMed ID: 1023248
[No Abstract] [Full Text] [Related]
6. [Biopharmaceutics and drug formulation].
Riccieri FM
Ann Ist Super Sanita; 1982; 18(3):541-6. PubMed ID: 7187842
[No Abstract] [Full Text] [Related]
7. [Factors influencing the bioavailability of drugs in the form of tablets].
Cid E
Pharm Acta Helv; 1974; 49(9-10):285-92. PubMed ID: 4462136
[No Abstract] [Full Text] [Related]
8. [Drug permeation through artificial lipoid membranes. 2. Mathematical description of substance transport].
Falk M; Fürst W
Pharmazie; 1973; 28(11):765-8. PubMed ID: 4791265
[No Abstract] [Full Text] [Related]
9. Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability.
Corti G; Maestrelli F; Cirri M; Zerrouk N; Mura P
Eur J Pharm Sci; 2006 Mar; 27(4):354-62. PubMed ID: 16364612
[TBL] [Abstract][Full Text] [Related]
10. Biopharmaceutical characterization of some synthetic purine drugs.
Chrzanowska M; Kuehn M; Hermann T; Neubert RH
Pharmazie; 2003 Jul; 58(7):504-6. PubMed ID: 12889537
[TBL] [Abstract][Full Text] [Related]
11. [Drug permeation through synthetic lipid membranes. 5. Permeability of synthetic lecithin membranes for a group of structurally similar heterocyclics].
Falk M; Fürst W; Hannig E; Böhm R
Pharmazie; 1974 Aug; 29(8):542-3. PubMed ID: 4409279
[No Abstract] [Full Text] [Related]
12. Lipophilicity and biological acitivity. Drug transport and drug distribution in model systems and in biological systems.
Kubinyi H
Arzneimittelforschung; 1979; 29(8):1067-80. PubMed ID: 40579
[TBL] [Abstract][Full Text] [Related]
13. An in vitro collodion-lipid membrane model for drug absorption studies.
Brandys J; Kwiek J; Witek J
Pol J Pharmacol Pharm; 1974; 26(5):519-26. PubMed ID: 4427813
[No Abstract] [Full Text] [Related]
14. [Drug permeation through synthetic lipoid membranes. 8. Mathematical description of substance transport with constant concentration in compartment A].
Fürst W; Falk M; Neubert R; Wiessner U; Klapper I
Pharmazie; 1976 Aug; 31(8):557-9. PubMed ID: 11511
[No Abstract] [Full Text] [Related]
15. Absorption-excipient-pH classification gradient maps: sparingly soluble drugs and the pH partition hypothesis.
Avdeef A; Kansy M; Bendels S; Tsinman K
Eur J Pharm Sci; 2008 Jan; 33(1):29-41. PubMed ID: 17983735
[TBL] [Abstract][Full Text] [Related]
16. [Drug permeation through synthetic lipoid membranes. 18. The mechanism of ion-pair permeation proton countertransport].
Neubert R; Fürst W; Schleiermacher H
Pharmazie; 1985 Jun; 40(6):426-7. PubMed ID: 4034654
[No Abstract] [Full Text] [Related]
17. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
[TBL] [Abstract][Full Text] [Related]
18. [Possibilities for the in vitro evaluation of bioavailability. 5. Compact peroral agents with basic drugs].
Fürst W; Neubert R; Bendas C; Lärm M; König A
Pharmazie; 1987 Jul; 42(7):458-60. PubMed ID: 3671472
[TBL] [Abstract][Full Text] [Related]
19. Permeability through DOPC/dodecane membranes: measurement and LFER modelling.
Huque FT; Box K; Platts JA; Comer J
Eur J Pharm Sci; 2004 Nov; 23(3):223-32. PubMed ID: 15489123
[TBL] [Abstract][Full Text] [Related]
20. Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination.
Schumacher GE
Am J Hosp Pharm; 1972 Apr; 29(4):339-43. PubMed ID: 5025265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
